PubMed · 11881991
PRO_SELECT: combining structure-based drug design and array-based chemistry for rapid lead discovery. 2. The development of a series of highly potent and selective factor Xa inhibitors.
Abstract
In silico screening of combinatorial libraries prior to synthesis promises to be a valuable aid to lead discovery. PRO_SELECT, a tool for the virtual screening of libraries for fit to a protein active site, has been used to find novel leads against the serine protease factor Xa. A small seed template was built upon using three iterations of library design, virtual screening, synthesis, and biological testing. Highly potent molecules with selectivity for factor Xa over other serine proteases were rapidly obtained.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
John W Liebeschuetz, Stuart D Jones, Phillip J Morgan, Chris W Murray, Andrew D Rimmer, Jonathan M E Roscoe, Bohdan Waszkowycz, Pauline M Welsh, William A Wylie, Stephen C Young, Harry Martin, Jacqui Mahler, Leo Brady, Kay Wilkinson. 2002-03-14. PRO_SELECT: combining structure-based drug design and array-based chemistry for rapid lead discovery. 2. The development of a series of highly potent and selective factor Xa inhibitors.. https://doi.org/10.1021/jm010944e
Cite the original work for its findings. Save a collection to share your selection of sources.